首页> 外国专利> Anti-cd79b antibody and immunosuppressant and their application

Anti-cd79b antibody and immunosuppressant and their application

机译:抗CD79B抗体和免疫抑制剂及其应用

摘要

FIELD: medicine.;SUBSTANCE: present group of inventions relates to biotechnology. What is presented is a humanised anti-CD79b antibody and its antigen-binding fragment produced of murine antibody MA79b and CD79b having a substantially analogous binding affinity thereto. A polynucleotide, a vector, a host cell and a method for producing the anti-CD79b antibody according to the invention; immunoconjugates, compositions and methods for cell growth inhibition, a method of treating an individual suffering cancer, a method of treating a proliferative disease and tumour in a mammal, a method for B-cell proliferation inhibition; a method for detecting the presence of CD79b in a sample and method for binding the antibody to the CD79b expressing cell are also disclosed.;EFFECT: given invention can find further application in therapy of the CD79b associated diseases.;86 cl, 20 tbl, 9 ex, 51 dwg
机译:田地:医学。物质:当前一组发明涉及生物技术。所提出的是一种人源化的抗CD79B抗体及其抗原结合片段,由鼠抗体MA79B和CD79B产生具有基本类似的结合亲和力。多核苷酸,载体,宿主细胞和根据本发明的抗CD79B抗体的制备方法;用于细胞生长抑制的免疫缀合物,组合物和方法,治疗个体患有癌症的方法,一种治疗哺乳动物中增殖性疾病和肿瘤的方法,一种用于B细胞增殖抑制的方法;还公开了一种检测样品中CD79b的存在的方法和用于将抗体结合到CD79b表达细胞的方法中。;效果:根据本发明可以在治疗CD79B相关疾病治疗方面进行进一步应用。; 86 CL,20 TBL, 9 ex,51 dwg

著录项

  • 公开/公告号RU2511410C3

    专利类型

  • 公开/公告日2021-06-15

    原文格式PDF

  • 申请/专利权人

    申请/专利号RU20100105232

  • 发明设计人

    申请日2008-07-15

  • 分类号C07K16/28;C07K19;C12N15/13;C12N15/63;C12N5/10;A61K39/395;A61P35;A61P37;

  • 国家 RU

  • 入库时间 2022-08-24 19:20:28

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号